NCT06286098View on ClinicalTrials.gov

Alpha Lipoic Acid in Pediatrics on Hemodialysis

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 2, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

April 1, 2027

Conditions
Hemodialysis ComplicationPediatric Kidney DiseaseCardiovascular Complication
Interventions
DRUG

Alpha lipoic acid

THIOTACID 600 MG ORIGINAL ® Tablets manufactured by EVA PHARMA

OTHER

Placebo

Placebo identical Tablets are manufactured by EVA PHARMA containing the same excipients without Alpha Lipoic Acid.

Trial Locations (1)

11381

New Pediatrics Hospital, Faculty of Medicine, Ain Shams University, Cairo

Sponsors

Collaborators (1)

Eva Pharma
All Listed Sponsors
collaborator

Eva Pharma

INDUSTRY

lead

Ain Shams University

OTHER